Targeting activated microglia in Alzheimer's pathology by intraventricular delivery of a phagocytosable MRI contrast agent in APP23 transgenic mice.

Source:http://linkedlifedata.com/resource/pubmed/id/19385010

Download in:

View as

General Info

PMID
19385010